tiprankstipranks
Accuray Incorporated (DE:XEJ)
FRANKFURT:XEJ

Accuray Stock Price & Analysis

0 Followers

XEJ Stock Chart & Stats

Day’s Range€0 - €0
52-Week Range― - ―
Previous Close€2.17
Volume0.00
Average Volume (3M)N/A
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)€88.74M
Total Debt (Recent Filing)€194.29M
P/E RatioN/A
Beta1.37
Next EarningsNov 01, 2022
EPS Estimate-€0.03
Next Dividend Ex-DateN/A
Dividend YieldN/A
EPS (TTM)N/A
Shares Outstanding93,499,500
R-SquaredN/A
Standard DeviationN/A
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
P/B Ratio-41.21
P/S Ratio0.47
P/CF Ratio30.80
P/FCF Ratio-28.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/EbitdaN/A
Price Target Upside240.09% Upside
Rating ConsensusModerate Buy
AlphaN/A
Number of Analyst Covering2


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

XEJ FAQ

What was Accuray’s price range in the past 12 months?
Currently, no data Available
What is Accuray’s market cap?
Currently, no data Available
When is Accuray’s upcoming earnings report date?
Accuray’s upcoming earnings report date is Nov 01, 2022 which is in 38 days.
    How were Accuray’s earnings last quarter?
    Accuray released its earnings results on Aug 10, 2022. The company reported -€0.041 earnings per share for the quarter, beating the consensus estimate of -€0.061 by €0.02.
      Is Accuray overvalued?
      According to Wall Street analysts Accuray’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does Accuray pay dividends?
        Accuray does not currently pay dividends.
        What is Accuray’s EPS estimate?
        Accuray’s EPS estimate is -€0.03.
          How many shares outstanding does Accuray have?
          Currently, no data Available
          What happened to Accuray’s price movement after its last earnings report?
          Accuray reported an EPS of -€0.041 in its last earnings report, beating expectations of -€0.061. Following the earnings report the stock price went up 7.9%.
            Which hedge fund is a major shareholder of Accuray?
            Among the largest hedge funds holding Accuray’s share is Royce & Associates LLC. It holds Accuray’s shares valued at 5M.

              ---

              Accuray Stock Analysis

              Smart ScoreUnderperform
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10
              2
              The Accuray Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
              Learn more about TipRanks Smart Score

              Company Description

              Accuray Incorporated

              Accuray, Inc. is a radiation oncology company. It engages in the development, manufacture and sale of treatment solutions that includes cyberKnife and tomo therapy systems, designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image-guided radiation therapy and adaptive radiation therapy. The company was founded by John R. Adler in 1990 and is headquartered in Sunnyvale, CA.

              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Abbott Labs
              Intuitive Surgical
              Stryker
              Becton Dickinson
              Edwards Lifesciences

              Popular Stocks

              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis